Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study
- PMID: 33861208
- PMCID: PMC8087974
- DOI: 10.2196/19564
Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study
Abstract
Background: Although fatigue is one of the most debilitating symptoms in patients with multiple sclerosis (MS), its pathogenesis is not well understood. Neurogenic, inflammatory, endocrine, and metabolic mechanisms have been proposed. Taking into account the temporal dynamics and comorbid mood symptoms of fatigue may help differentiate fatigue phenotypes. These phenotypes may reflect different pathogeneses and may respond to different mechanism-specific treatments. Although several tools have been developed to assess various symptoms (including fatigue), monitor clinical status, or improve the perceived level of fatigue in patients with MS, options for a detailed, real-time assessment of MS-related fatigue and relevant comorbidities are still limited.
Objective: This study aims to present a novel mobile app specifically designed to differentiate fatigue phenotypes using circadian symptom monitoring and state-of-the-art characterization of MS-related fatigue and its related symptoms. We also aim to report the first findings regarding patient compliance and the relationship between compliance and patient characteristics, including MS disease severity.
Methods: After developing the app, we used it in a prospective study designed to investigate the brain magnetic resonance imaging correlates of MS-related fatigue. In total, 64 patients with MS were recruited into this study and asked to use the app over a 2-week period. The app features the following modules: Visual Analogue Scales (VASs) to assess circadian changes in fatigue, depression, anxiety, and pain; daily sleep diaries (SLDs) to assess sleep habits and quality; and 10 one-time questionnaires to assess fatigue, depression, anxiety, sleepiness, physical activity, and motivation, as well as several other one-time questionnaires that were created to assess those relevant aspects of fatigue that were not captured by existing fatigue questionnaires. The app prompts subjects to assess their symptoms multiple times a day and enables real-time symptom monitoring through a web-accessible portal.
Results: Of 64 patients, 56 (88%) used the app, of which 51 (91%) completed all one-time questionnaires and 47 (84%) completed all one-time questionnaires, VASs, and SLDs. Patients reported no issues with the usage of the app, and there were no technical issues with our web-based data collection system. The relapsing-remitting MS to secondary-progressive MS ratio was significantly higher in patients who completed all one-time questionnaires, VASs, and SLDs than in those who completed all one-time questionnaires but not all VASs and SLDs (P=.01). No other significant differences in demographics, fatigue, or disease severity were observed between the degrees of compliance.
Conclusions: The app can be used with reasonable compliance across patients with relapsing-remitting and secondary-progressive MS irrespective of demographics, fatigue, or disease severity.
Keywords: depression; fatigue; mobile application; mobile phone; multiple sclerosis; real-time assessment.
©Miklos Palotai, Max Wallack, Gergo Kujbus, Adam Dalnoki, Charles Guttmann. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 16.04.2021.
Conflict of interest statement
Conflicts of Interest: MP and MW reported no disclosures. GK is the director of the Mobilengine. AD is the CEO of the Mobilengine. CG has received support from Mobilengine (free use of platform and programming by Mobilengine Engineers), the National Multiple Sclerosis Society, the International Progressive Multiple Sclerosis Alliance, the US Office for Naval Research, and travel support from Roche Pharmaceuticals; CG owns stock in Roche, Novartis, GlaxoSmithKline, Alnylam, Protalix Biotherapeutics, Arrowhead Pharmaceuticals, Cocrystal Pharma, and Sangamo Therapeutics.
Figures






Similar articles
-
A Mobile App for Measuring Real Time Fatigue in Patients with Multiple Sclerosis: Introducing the Fimo Health App.Brain Sci. 2021 Sep 18;11(9):1235. doi: 10.3390/brainsci11091235. Brain Sci. 2021. PMID: 34573257 Free PMC article. Review.
-
Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.JMIR Mhealth Uhealth. 2020 Oct 27;8(10):e22108. doi: 10.2196/22108. JMIR Mhealth Uhealth. 2020. PMID: 33107827 Free PMC article.
-
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.Mult Scler. 2002 Dec;8(6):523-6. doi: 10.1191/1352458502ms839oa. Mult Scler. 2002. PMID: 12474995
-
Feasibility of a theory-informed mobile app for changing physical activity in youth with multiple sclerosis.Mult Scler Relat Disord. 2022 Feb;58:103467. doi: 10.1016/j.msard.2021.103467. Epub 2021 Dec 20. Mult Scler Relat Disord. 2022. PMID: 34954651
-
Mobile App-Based Self-Report Questionnaires for the Assessment and Monitoring of Bipolar Disorder: Systematic Review.JMIR Form Res. 2021 Jan 8;5(1):e13770. doi: 10.2196/13770. JMIR Form Res. 2021. PMID: 33416510 Free PMC article. Review.
Cited by
-
A Smartphone-based Application for Self-Management in Multiple Sclerosis.J Healthc Eng. 2021 Jun 16;2021:6749951. doi: 10.1155/2021/6749951. eCollection 2021. J Healthc Eng. 2021. PMID: 34221301 Free PMC article.
-
Application of telemedicine in fatigue management for patients with multiple sclerosis: A scoping review.PLoS One. 2025 Jul 17;20(7):e0327563. doi: 10.1371/journal.pone.0327563. eCollection 2025. PLoS One. 2025. PMID: 40674323 Free PMC article.
-
A mobile app (IDoThis) for multiple sclerosis self-management: development and initial evaluation.BMC Med Inform Decis Mak. 2022 Dec 13;22(1):328. doi: 10.1186/s12911-022-02078-z. BMC Med Inform Decis Mak. 2022. PMID: 36514043 Free PMC article.
-
A Mobile App for Measuring Real Time Fatigue in Patients with Multiple Sclerosis: Introducing the Fimo Health App.Brain Sci. 2021 Sep 18;11(9):1235. doi: 10.3390/brainsci11091235. Brain Sci. 2021. PMID: 34573257 Free PMC article. Review.
-
Digital Biomarkers and AI for Remote Monitoring of Fatigue Progression in Neurological Disorders: Bridging Mechanisms to Clinical Applications.Brain Sci. 2025 May 21;15(5):533. doi: 10.3390/brainsci15050533. Brain Sci. 2025. PMID: 40426703 Free PMC article.
References
-
- Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG. The prevalence of MS in the United States. Neurology. 2019 Feb 15;92(10):1029–40. doi: 10.1212/wnl.0000000000007035. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical